- Home
- CORT vs FRPT Comparison
CORT vs FRPT Comparison
Compare CORT & FRPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- FRPT
- Stock Information
- Founded
- CORT 1998
- FRPT 2004
- Country
- CORT United States
- FRPT United States
- Employees
- CORT N/A
- FRPT N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- FRPT Packaged Foods
- Sector
- CORT Health Care
- FRPT Consumer Staples
- Exchange
- CORT Nasdaq
- FRPT Nasdaq
- Market Cap
- CORT 7.6B
- FRPT 3.1B
- IPO Year
- CORT N/A
- FRPT 2014
- Fundamental
- Price
- CORT $71.32
- FRPT $54.03
- Analyst Decision
- CORT Strong Buy
- FRPT Buy
- Analyst Count
- CORT 4
- FRPT 16
- Target Price
- CORT $139.00
- FRPT $118.80
- AVG Volume (30 Days)
- CORT 659.5K
- FRPT 1.5M
- Earning Date
- CORT 10-29-2025
- FRPT 11-03-2025
- Dividend Yield
- CORT N/A
- FRPT N/A
- EPS Growth
- CORT N/A
- FRPT 28.97
- EPS
- CORT 1.11
- FRPT 0.66
- Revenue
- CORT $716,080,000.00
- FRPT $1,044,013,000.00
- Revenue This Year
- CORT $30.62
- FRPT $16.39
- Revenue Next Year
- CORT $37.68
- FRPT $13.39
- P/E Ratio
- CORT $63.88
- FRPT $81.62
- Revenue Growth
- CORT 25.71
- FRPT 19.30
- 52 Week Low
- CORT $37.82
- FRPT $52.09
- 52 Week High
- CORT $117.33
- FRPT $164.07
- Technical
- Relative Strength Index (RSI)
- CORT 51.04
- FRPT 40.14
- Support Level
- CORT $67.32
- FRPT $52.70
- Resistance Level
- CORT $74.79
- FRPT $55.55
- Average True Range (ATR)
- CORT 2.43
- FRPT 2.19
- MACD
- CORT 0.10
- FRPT 0.20
- Stochastic Oscillator
- CORT 53.55
- FRPT 31.24
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About FRPT Freshpet Inc.
Freshpet produces and sells premium fresh pet food through its company-owned refrigerators placed in grocery, mass and club, pet specialty, and natural stores. Freshpet primarily targets dogs (96% of 2024 sales), with cats and treats comprising the rest of its sales. Geographically, the company's home US market, where all its food is produced, accounts for about 98% of sales, with exports to Canada, the United Kingdom, and other European countries accounting for the remaining balance.